December 8, 2022

Medical Trend

Medical News and Medical Resources

Taiwan former president’s Wife: Wu Shu-chen’s eyelid found malignant tumor

Taiwan former president’s Wife: Wu Shu-chen’s eyelid found malignant tumor.



 

Taiwan former president’s Wife: Wu Shu-chen’s eyelid found malignant tumor, doctors analyzed “this kind of cancer” that is most likely to be ignored.

 

picture source: UDN

 

Wu Shu-chen, the wife of Chen Shui-bian(the former president of Taiwan), recently had a malignant tumor in her left upper eyelid removed and underwent eyelid reconstruction surgery.

Ophthalmologists point out that 80% of eyelid tumors are benign moles, xanthelasmas, cysts, granulomas, and hemangiomas, and 20% are malignant tumors. Most of them are basal cell carcinomas with less metastasis and better prognosis, which often grow on the lower eyelid or the inside of the eye.

The remaining 10% are more likely to metastasize, such as squamous cell carcinoma of the lower eyelid and sebaceous carcinoma of the upper eyelid. The latter is often mistaken for a benign chalazion and is ignored. Vigilance should be increased.

Many ophthalmology outpatients complain about “bulging eyelid”. There are two most common types. The pain is usually benign pinhole (stye), with inflammation symptoms of redness, swelling, heat and pain;
The painless is often caused by the accumulation of sebaceous glands chalazion, most of the heat will disappear.

If the mass recurs and cannot be cured, a pathological section is usually done to confirm whether it is a malignant tumor.

 

The most common malignant eyelid tumor is “basal cell carcinoma”, accounting for about 90%. The first place is the lower eyelid, and the second place is the inner side of the eye. The appearance is usually a convex one with an ulcer in the middle. the depression.

Basal cell carcinoma is relatively non-metastatic, and mostly invades locally. As long as it is removed cleanly, the prognosis of the patient is also better.

The remaining 10% of malignant eyelid tumors are “squamous cell carcinoma” that occurs in the lower eyelid and “sebaceous carcinoma” that occurs in the upper eyelid. Although rare, they are more likely to metastasize or invade the nerves.

 

The sebaceous glands of the upper eyelid are relatively prosperous, and both sebaceous carcinoma and chalazion are prone to grow here, and both have lumps, so the two are often confused. If the chalazion treatment is ineffective, the possibility of sebaceous carcinoma should be carefully evaluated.

If the lump is repeatedly inflamed and hardened, or if there is a condition such as “eyelashes falling off” that does not occur in the eye of a needle, you must be especially careful, it may be cancer.

The director of the Department of Ophthalmology of the Taiwan Military General Hospital said that every year, one or two patients with malignant tumors of the eyelid are seen in the clinic.

It is estimated that there may be dozens of cases in Taiwan every year.

Most of them are elderly people over 50 to 60 years old, and women are slightly more than men. Some patients complained of “recurrence of needle eyes”, sometimes accompanied by ulcers and wounds, so be careful.

The first step in the treatment is to do excision in the ophthalmology clinic, and then send the pathological section.

If it is found to be malignant, it is necessary to arrange a second operation to do a wider resection to prevent cancer cells from metastasizing through the nasal cavity and blood flow next to the orbit.

The remaining eyelid after surgery may cause incomplete eye closure, so it should be temporarily covered with gauze to prevent the cornea from drying out.

Next, eyelid reconstruction surgery is arranged, usually 3 to 6 months after reconstruction, 80% of patients can return to normal eye opening and closing.

Patients also need regular follow-up examinations to confirm whether cancer cells have metastasized; if they have metastasized, radiation therapy is required.

 

 

https://udn.com/news/story/7266/6678048

(source:internet, reference only)


Disclaimer of medicaltrend.org